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Summary
Decline in muscle strength with aging is an important predictor of
health trajectory in the elderly. Several factors, including genet-
ics, are proposed contributors to variability in muscle strength. To
identify genetic contributors to muscle strength, a meta-analysis
of genomewide association studies of handgrip was conducted.
Grip strength was measured using a handheld dynamometer in
27 581 individuals of European descent over 65 years of age from
14 cohort studies. Genomewide association analysis was con-
ducted on ~2.7 million imputed and genotyped variants (SNPs).
Replication of the most significant findings was conducted using
data from 6393 individuals from three cohorts. GWAS of lower
body strength was also characterized in a subset of cohorts. Two
genomewide significant (P-value< 5 3 108) and 39 suggestive
(P-value< 5 3 105) associations were observed from meta-
analysis of the discovery cohorts. After meta-analysis with
replication cohorts, genomewide significant association was
observed for rs752045 on chromosome 8 (b = 0.47, SE = 0.08, P-
value = 5.20 3 1010). This SNP is mapped to an intergenic region
and is located within an accessible chromatin region (DNase
hypersensitivity site) in skeletal muscle myotubes differentiated
from the human skeletal muscle myoblasts cell line. This locus
alters a binding motif of the CCAAT/enhancer-binding protein-b
(CEBPB) that is implicated in muscle repair mechanisms. GWAS of
lower body strength did not yield significant results. A common
genetic variant in a chromosomal region that regulates myotube
differentiation and muscle repair may contribute to variability in
grip strength in the elderly. Further studies are needed to
uncover the mechanisms that link this genetic variant with
muscle strength.
Key words: aging; genomewide association; meta-analysis;
muscle strength; older adults; SNP.
Introduction
Loss of muscle strength, ‘dynapenia’, is a common characteristic of aging
and is associated with increased risk of frailty, falls, hospitalizations and
mortality (Moreland et al., 2004; Xue et al., 2010; Marsh et al., 2011).
In particular, handgrip strength is found to be predictive of overall and
exceptional survival (Willcox et al., 2006) and other key age-related
outcomes (Marsh et al., 2011; McLean et al., 2014). For example, poor
handgrip strength among healthy middle-aged subjects was found to
significantly predict functional limitations and disability 25 years later
(Rantanen et al., 1999). The biology that drives muscle strength decline
is complex, with hormonal changes, inflammatory pathway activation,
mitochondrial physiology, malnutrition, and exercise all likely playing a
role (Walston, 2012; Gonzalez-Freire et al., 2014). Further identification
of biologically relevant pathways that influence muscle strength main-
tenance and decline could be important in the development of future
treatment or prevention strategies. Hence, genetic approaches to the
identification of novel biology may be helpful.
The heritability of muscle strength in older adults has been estimated
to be between 40 and 65% (Tiainen et al., 2004; Matteini et al., 2010).
Previously published reports have been limited to candidate gene
analyses in small cohorts of older adults (Arking et al., 2006; Serena
Dato et al., 2012; S Dato et al., 2014). These studies have highlighted
potentially important biologic pathways associated with handgrip
strength but have been unable to identify a significant replicated locus.
In spite of the importance of this phenotype for health and function, to
date, no genomewide association study (GWAS) has been published on
handgrip strength.
Because of the large, well-characterized cohorts represented in the
CHARGE consortium, grip strength and genomewide genotype data
from 17 cohort studies (14 discovery and three replication cohorts) of
older adults were included in this meta-analysis. We sought to identify
potential genetic influences that underlie measures of strength in adults
aged 65 years and older.
Results
Discovery set
A genomewide meta-analysis included 27 581 community-dwelling men
and women of European ancestry from a discovery set of 14 participat-
ing cohorts. On average across the cohorts, there were 2 725 778 SNPs
analyzed, with SNPs analyzed per cohort ranging from 2 332 998 to
4 930 728. Sample size and cohort characteristics are found in Table S1
(Supporting information). There were no significant differences in age,
strength, or gender distributions between the discovery and replication
cohorts. Q-Q and Manhattan plots are shown in Figs S1, S2 (Supporting
information). In the discovery set meta-analysis, 2 SNPs reached
genomewide significance (rs3121278 chr10: P-value = 2.68 9 108
and rs752045 chr8: P-value = 3.09 9 108). An additional 39 SNPs
reached suggestive significance in eight regions on chromosomes 1 (one
SNP), 5 (two highly correlated SNPs), seven (seven SNPs), 8p23 (two
SNPs), 8q12 (14 SNPs), 10 (11 SNPs), 11 (three SNPs), and 12 (one SNP)
(Table S4). Chromosomes 1, 5, and 12 loci were not pursued in
subsequent analysis due to the fact that there was only a single SNP in
the locus with suggestive significance. The five regions that remained
suggestive are intergenic. Table 1 shows the lead SNP per region with
meta-analyzed results from discovery, replication as well as combined
discovery and replication cohorts. Regional plots (created using Locus
zoom http://csg.sph.umich.edu/locuszoom/) are displayed in Fig. 1.
Replication cohorts
Significant and suggestive SNPs on chromosomes 7, 8p23, 8q12, 10, and
11 were tested in the replication cohorts and in the combined discovery/
replication set. First, the most significant discovery SNP, rs3121278, was
significant in the replication (P-valuerep = 0.01), yet the effect was in the
opposite direction from the discovery set resulting in a decrease in
significance in the combined analysis (P-valuedisc+rep = 6.18 9 10
5).
Next, SNP rs752045 on chromosome 8p23 showed an association with
grip strengthupon replication and thedirectionwas consistentwith that of
the discovery set (P-valuerep = 4.80 9 10
3), leading to increased signif-
icance in the combined set (P-valuedisc+rep = 5.20 9 10
10). Likewise, the
second best SNP on chromosome 11 rs11235843 showed consistent
direction and magnitude of effect in the replication cohorts
(P-valuerep = 4.70 9 10
2) and significance in the combined set increased
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(P-valuedisc+rep = 1.19 9 10
6), although it still failed to reach the preset
threshold for genomewide significance. Lastly, SNPs in suggestive areas of
chromosome 7 and 8q12 showed no effect upon replication. Combined
results from these regions showed slightly decreased significance,
although P-values were still in the range of suggestive association.
Lower body strength
A meta-analysis of genomewide association analysis of lower body
strengthwas conducted as a secondarymuscle strength phenotype. There
were no genomewide significant associations identified (Fig. S3). Themost
significant association was observed for rs16831 on chr11
(P = 6.07 9 107; Table S5). The closest gene was an uncharacterized
gene LOC101929497 approximately 187 Mb away. We also looked up
the top signals from the grip strength analysis; however, these loci were
not significantly associatedwith lower body strength (P > 0.05; Table S6).
Functional annotation
Results from the functional annotation analysis are shown in Table 2.
SNPs in the chromosome 7, 10, and 11 regions showed direct links to the
regulatory chromatin states in muscle tissue or accessible chromatin
states according to ChIP-seq and DNase-seq data. First, top discovery
SNPs rs3121278 and rs752045 were located within accessible chromatin
regions in skeletal muscle myotubes differentiated from the skeletal
muscle myoblast (HSMM) cell lines. The suggestive SNP rs2796549 also
was located within an accessible chromatin region in skeletal muscle
myoblasts. Next, the three suggestive chromosome 11 SNPs localized to
motifs predicted to be regulatory elements, promoters, and enhancers,
in skeletal muscle myoblasts. The top suggestive chromosome 7 SNP
rs1819054 was not shown to affect gene regulatory elements in muscle-
related tissues; however, three SNPs within the region were predicted to
localize in regulatory enhancers in skeletal muscle myoblasts. This
chromosome 7 locus was significantly enriched for enhancer/promoter
elements in muscle cells compared with other muscle types (P-
value = 9.9 9 105). Suggestive SNPs on chromosomes 7, 8p12, and
10 were also predicted to alter binding motifs of the CCAAT/enhancer-
binding protein beta, delta, and gamma family (CEBPB, CEBPD, and
CEBPG), zinc finger protein 263 (ZNF263), and the nuclear factor kappa
beta (NF-kB).
eQTL analysis
The top five SNPs listed in Table 1 were queried as index SNP in skeletal
muscle and brain tissue eQTL. For the locus on chromosome 10
(rs3121278), a proxy SNP rs3121327 (r2 = 0.87) was significantly
associated with gene transcript zinc finger protein 33B (ZNF33B) in
prefrontal cortex tissue. No other associations were observed for the
other loci queried.
Discussion
The combined discovery and replication meta-analysis resulted in
increased significance in the chr8p23 locus, exceeding genomewide
significance (rs752045, P-value = 3.18 9 1010 and rs890022, P-
value = 4.80 9 108). We conducted a genomewide association anal-
ysis of lower body strength in a smaller sample as a second trait for
muscle strength. However, there were no significant genetic associations
observed for lower body strength, and the results did not confirm the
top signals from the grip strength analysis.T
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The chromosome 8p23 locus—rs752045—is over 500 kb away from
the closest gene genomewide significant association. However, accord-
ing to the ENCODE’s DNase I hypersensitivity data, rs752045 is located in
an accessible chromatin region, indicating possible regulatory activities in
skeletal muscle myotubes differentiated from the HSMM cell line. This
SNP alters a binding motif of the CCAAT/enhancer-binding protein beta
(CEBPB). The effect allele (G) decreases a score developed to define the
effect of variants on regulatory motifs (the position weight matrix (PWM)
score). In this case, the PWM score for CEBPB decreased from 11.6 to
0.2, indicating a prediction of decreased binding affinity of CEBPB. The
PWM scores were reported as part of the HaploReg database (http://
www.broadinstitute.org/mammals/haploreg/detail_v4.1.php?-
query=&id=rs752045). CEBPB is a transcription factor that regulates
genes for inflammatory responses, including the IL-1 response element in
the IL-6 gene (Harries et al., 2012). IL-6 levels are strongly related to
muscle strength, functional decline, and sarcopenia in older adults
Chromosome 7 Chromosome 8p23  
Chromsome 8q12  Chromosome 10 Zoom plot
Chromosome 11 Zoom plot
(A) (B)
(D)
(E)
(C)
Fig. 1 Regional association plots for the most significant associations from the meta-analysis of handgrip strength in the discovery set. The figures display –log10 P-values
for SNPs that passed quality control for the analysis of handgrip strength for locus on (A) chromosome 7, (B) chromosome 8p23, (C) chromosome 8q12, (D) chromosome 10,
and (E) chromosome 11. The degree of linkage disequilibrium (r2) is displayed in the following categories: r2 ≥ 0.8, ≥ 0.6, ≥0.4, ≥0.2, and ≥0.
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Cesari et al., 2004; Kilgour et al., 2013). CEBPB is also important in
macrophage function, which plays a crucial role in normal skeletal
muscle repair (Rahman et al., 2012). In addition, expression of CEBPB in
blood leukocytes has been positively associated with muscle strength in
humans, further supporting the possible link between gene variants and
a decline in skeletal muscle function in older age groups (Ruffell et al.,
2009).
SNPs in associated regions on chromosomes 7 and 11 are proximal
to genes PLEKHB1 (chr11), FAM3C (chr7), and WNT16 (chr7), and the
latter has been associated with bone mineral density, osteoporosis, and
fracture risk. Both loci represent promoters or enhancers in regulatory
chromatin states in skeletal muscle myoblasts in ENCODE and Epige-
netic Roadmap data. PLEKHB1 protein interacts with ACVR1, which is
involved in fibrodysplasia ossificans progressiva (FOP), a rare congenital
disorder that causes bone formation in muscles, tendons, ligaments,
and connective tissues. Additionally, SNPs on the chromosome 7 locus
were predicted to alter binding motifs of the CCAAT/enhancer-binding
protein beta, delta, and gamma family (CEBPB, CEBPD, and CEBPG)
and the nuclear factor kappa-b (NF-kB). In addition to the CEBPB
association with muscle discussed above, CEBPD has also been linked to
differential expression of myostatin, a skeletal muscle inhibitory factor
that can lead to muscle strength declines (Allen et al., 2010). CEBPG
likely plays a role in cell growth arrest in the setting of inflammation
activation (Huggins et al., 2013). NF-kB is the nuclear transcription
factor that acts as a gate-keeping molecule for activation of inflam-
matory signaling (Guttridge et al., 2000; Ershler, 2007). Subtle alter-
ation in expression of these factors may well alter muscle tissue
maintenance with aging and would in turn lead to grip strength
declines.
Last, the suggestive region of chromosome 10 is 20 kb away from the
BMS1L gene, a ribosome assembly protein which has no known function
in skeletal muscle. This group of three SNPs also had relevant data from
ENCODE, indicating that DNase-hypersensitive sites were found in
skeletal muscle myotubes, in particular those differentiated from HSMM
cell lines and osteoblasts.
There are several strengths to this study. First, we have identified 14
cohorts including 27 581 older adults that have appropriate handgrip
strength measurements and genotypes necessary to perform a study of
this kind. Next, the ability to explore potential findings with the
ENCODE data provides an important biologic window into the potential
relevance of the genetic findings. There are potential limitations to this
study as well. First, a cross-sectional, one-time handgrip, or lower body
strength measure may not be the best phenotypic measurement to
capture age-related strength decline as a phenotype. Although the
lower body strength analysis was consistent with grip strength, due to
sample size restrictions, the age cutoff for lower body strength was set
at 50 years of age. The correlation between grip and lower body
strength has been reported to be in the range of 0.4–0.6, suggesting
that both measure the same construct of muscle strength (Bohannon
et al., 2012).
This cross-sectional study was designed to determine genetic variants
associated with grip strength in persons over the age of 65 years.
Strength in old age is thought to be a reflection of both the peak
strength and the rate of decline. Similarly, cross-sectional analysis with
phenotypes such as bone density or cognitive performance still have
been useful for understanding rate of decline with age. Here, we studied
individuals over 65 years of age; thus, the majority are predicted to have
already entered the decline phase. Future genetic studies should
consider examining changes in muscle strength to focus on the potential
determinants of age-related decreases that are commonly observed with
aging, as trajectories of strength decline were not widely available
among these cohorts.
Despite limitations, these results suggest biologically plausibility.
Chromosome 7 locus was significantly enriched for enhancer/promoter
elements in muscle cells compared with other muscle types. C/EBP
transcription factors have been linked to a number of metabolic and
inflammatory processes that would be expected to influence skeletal
muscle, and have been previously implicated in other cohorts. These
findings provide additional rationale for the further study of C/EBP-
related pathways and their overall influence in the development of
dynapenia in older adults. Future studies should follow up these findings
to determine whether there are potential epigenetic changes, or even
whether there are significant CEBPB expression differences in skeletal
muscle samples between young and old humans.
Experimental procedures
Subjects
The discovery phase of this GWAS was conducted on 27 581 subjects
from the following 14 participating studies of the Cohorts for Heart
and Aging Research in Genomic Epidemiology Consortium (CHARGE);
the Age, Gene/Environment Susceptibility Study (AGES); the Cardio-
vascular Health Study (CHS); the Framingham Heart Study (FHS); the
Health, Aging, and Body Composition (Health ABC) Study; the Health
and Retirement Study (HRS); the InCHIANTI Study; the Lothian Birth
Cohort Studies (1921 and 1936); the Osteoporotic Fractures in Men
Study (MrOS); Religious Order Study, Memory and Aging Project (MAP/
ROS); the Study of Health in Pomerania (SHIP); the Study of
Osteoporotic Fractures (SOF); the Tasmanian Study of Cognition and
Gait (TasCog); and the Twins UK Study. Replication cohorts contributed
6393 subjects from three cohorts, the Atherosclerosis Risk in Commu-
nities Study (ARIC) and the Rotterdam Studies I and II. Detailed
description of each cohort and references are included in the
Appendix S1 (Supporting information). Each cohort’s study protocol
was reviewed and approved by their respective institutional review
board.
In parallel to grip strength analysis, a GWAS analysis of lower body
strength was conducted as an additional measure of muscle strength in
9822 individuals over the age of 50 years from seven studies: AGES,
Baltimore Longitudinal Study on Aging (BLSA), InCHIANTI, CHS, FHS,
Health ABC, and MAP/ROS.
Phenotyping
All participants with at least one recorded grip strength measurement
(kg) (Table S1) were included in the analysis. The primary outcome was
defined as the maximal value across available trials. Exclusion criteria for
grip strength analysis included age <65 years, non-Caucasian origin via
self-report or identical-by-state (IBS) clustering of the GWAS data, and
missing grip strength data. Additional exclusion based on self-reported
pain, surgery, or osteoarthritis in the dominant hand was considered.
However, as adequate data across all cohorts were not available, these
exclusions were not implemented in this analysis. Handgrip was
employed as a nontransformed, continuous trait.
For lower body strength, all studies used performance-based assess-
ment methods reporting measures in kg or in Newton-meter (Table S2).
If multiple examinations were performed, the maximum measurement
was used. Exclusion for lower body strength analysis was consistent with
grip strength; however, due to sample size restrictions, the age cutoff
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was set at 50 years of age. Lower leg strength was analyzed as a
nontransformed, continuous trait.
Additional variables used in this study included gender, age, standing
height, and weight for both grip and lower body strength. Each of these
characteristics was collected with handgrip and/or lower body strength
according to study-specific protocols.
Genotyping
Each cohort performed its own genomewide genotyping and genotype
imputation based on NCBI Build 36 (http://www.ncbi.nlm.nih.gov/SNP/).
Table S3 (Supporting information) summarizes genotyping platform,
imputation methods, quality control methods, and final SNP count per
cohort. Results are reported for each SNP for as many cohorts as were
available via genotyping and imputation.
Statistical analysis
Multiple linear regression models were built for genotyped and imputed
SNPs on maximal grip strength (kg), adjusted for age, gender, height,
weight, study site (when necessary), and principal components to
control for population stratification (Price et al., 2006). An additive
model with the count of the number of variant alleles was used for all
analyses. Handgrip strength was used as a continuous trait, and the
regression results reflect an increase or decrease in strength (kg) per
additive allele. Test statistics for genomewide association analysis were
combined using METAL (Willer et al., 2010). Inverse variance-weighted
meta-analysis was performed using a fixed-effects model of b-estimates
and standard errors from each cohort. In the meta-analysis of discovery
GWAS, between-study heterogeneity was tested using Cochran’s Q test
as implemented in METAL. A threshold of P-value <5 9 108 was
utilized to determine genomewide statistical significance, while P-values
<1 9 105 were considered suggestive. SNPs that met these signifi-
cance thresholds were then evaluated in a set of 3 replications cohorts,
as well as analyzed jointly in discovery and replication cohorts
(n = 33 974).
For the leg strength analysis, as the unit of measure differed by
cohort (kg or Nm), a sample size-weighted meta-analysis was
conducted where an arbitrary reference allele is selected and a z-
statistic summarizing the magnitude and the direction of effect relative
to the reference allele was calculated and weighted by the square root
of the sample size of each study. Thresholds for statistical significance
set for the handgrip analysis were utilized for the leg strength results as
well.
Using the HaploReg tool (http://compbio.mit.edu/HaploReg.), we
annotated potential regulatory functions of our GWAS SNPs and loci
based on experimental epigenetic data, including open chromatin and
histone modifications, and transcription factor binding sites in human
cell lines and tissues (Ward & Kellis, 2012). First, we constructed
haplotype blocks for GWAS most significant, or lead, SNPs and SNPs in
high linkage disequilibrium (LD, r2 > 0.8) with GWAS lead SNPs. Then,
we identified regulatory elements including enhancers and promoters
estimated by chromatin states in the haplotype blocks across 98
healthy human tissues/normal cell lines available in the ENCODE Project
and the Epigenomics Roadmap Project (Encode and Consortium 2011;
Chadwick, 2012). The regulatory elements were annotated by an
algorithm named ChromHMM, and data were downloaded from
HaploReg3 (Ernst & Kellis, 2012; Ward & Kellis, 2012). To evaluate
whether GWAS loci were enriched with regulatory elements and
corresponded to the DNase I-hypersensitive sites (DHSs) in muscle
tissues, we performed a promoter/enhancer enrichment analysis using
a hypergeometric test to compare the abundance of regulatory
elements in muscle tissues (9 relevant muscle tissues/cell lines) to
nonmuscle tissues (89 tissues/cell lines) in the haplotype blocks of a
GWAS locus. A permutation was performed to correct for multiple
testing. Permutation P-values <0.05 were considered statistically
significant.
Expression quantitative trait loci (eQTL) analysis
Proxy SNPs in linkage disequilibrium (r2>0.8) in European ancestry
populations were identified for handgrip for the top five most significant
SNPs as the lead SNPs using SNAP (Johnson et al., 2008). Index SNPs and
proxies were identified in a collected database of expression SNP (eSNP)
results. The collected eSNP results met criteria for statistical thresholds
for association with gene transcript levels as described in the original
papers. A general overview of a subset of >50 eQTL studies has been
published (Zhang et al., 2014), with specific citations for >100 studies.
For the current query, we focused our search to skeletal muscle and
brain tissue (Keildson et al., 2014; Zhang et al., 2014). Details on tissue
samples can be found in the Appendix S1 (Supporting information).
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